Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas

Neuropathology and Applied Neurobiology

Volumn 24, Issue 6, 1998, Pages 434-440

  Bennetto, L ^e   Foreman, N ^e   Harding, B ^a   Hayward, R ^a   Ironside, J ^b   Love, S ^c   Ellison, D ^d  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Ependymoma; Glioma; Ki 67; MiB 1; Prognosis

Indexed keywords

FORMALDEHYDE; MONOCLONAL ANTIBODY KI 67; PARAFFIN;

ADJUVANT THERAPY; ADOLESCENT; ANTIBODY LABELING; ARTICLE; CHILD; CHILDHOOD CANCER; EPENDYMOMA; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; INFANT; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR CLASSIFICATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRANIAL FOSSA, POSTERIOR; EPENDYMOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKULL BASE NEOPLASMS; SURVIVAL RATE;

EID: 0032407745     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00143.x     Document Type: Article

References (35)

1. Bloom HJ, Glees J, Bell J. The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-81. Int J Radiation Oncology Biol Phys 1990; 18: 723-49
2. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. Fascicle 10 of the Atlas of Tumor Pathology Washington DC: Armed Forces Institute, of Pathology, 1995
3. Daumas-Duport C. Histological grading of gliomas. Currt Opin Neurol Neurosurg 1992; 5: 924-31
4. Dohrmann GJ, Farwell JR, Flannery JT. Ependymomas and ependymoblastomas in children. J Neurosurg 1976; 45: 273-83
5. Duncan JA, Hoffman HJ. Intracranial ependymomas. In: Brain Tumors., Eds AH Kaye, ER Laws. New York: Churchill Livingstone, 1995: 495-504
6. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psych 1995; 59: 413-9
7. Ferrante L, Mastronardi L, Schettini G, Lunardi P, Fortuna A. Fourth ventricle ependymomas. A study of 20 cases with survival analysis. Acta Neurochirurgica 1994; 131: 67-74
8. Foreman NK, Love S, Thorne R. Intracranial ependymomas: analysis of prognostic factors in a population based series. Ped Neurosurg 1996; 24: 119-25
9. Gerszten PC, Pollack IF, Martínez AJ, Lo K-H, Janosky J, Albright AL. Intracranial ependymomas of childhood: lack of correlation of histopathology and clinical outcome. Path Res Pract 1996; 192: 515-22
10. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol 1987; 74: 179-82
11. Hamilton RL, Pollack IF. The molecular biology of ependymomas. Brain Pathol 1997; 7: 807-22
12. Healey EA, Barnes PD, Kupsky WJ et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991; 28: 666-72
13. Hsu DW, Louis DN, Efird JT, Hedley-White ET. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 1997; 56: 857-65
14. Ilgren EB, Stiller CA, Hughes JT, Silberman D, Steckel N, Kaye A. Ependymomas: a clinical and pathological study. II. Survival features. Clin Neuropathol 1984; 3: 122-7
15. Jayawickreme DP, Hayward RD, Harkness WF. Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Child's Nerv Syst 1995; 11: 409-13
16. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System Berlin: Springer 1993
17. Kros JM, Hop WC, Godschalk JJ, Krishnadath KK. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 1996; 78: 1107-13
18. Lyons MK, Kelly PJ. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 1991; 28: 659-65
19. Mork SJ, Loken AC. Ependymoma. Cancer 1977; 40: 907-15
20. Nazar GB, Hoffman HJ, Becker LE, Jenkin D. Humphreys RP, Hendrick EB. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 1990; 72: 408-17
21. Papadopoulos DP, Giri S, Evans RG. Prognostic factors and management of intracranial ependymomas. Anticancer Research 1990; 10: 689-92
22. Perilongo G, Massimino M. Sotti G et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Medical and Pediatric Oncology 1997; 29: 79-85
23. Pollack IF, Gerszten PC, Martinez AJ et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995; 37: 655-67
24. Raghavan R, Steart PV, Weller RO. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study. Neuropathol Appl Neurobiol 1990; 16: 123-33
25. Rezai A, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. J Neurosurg 1996; 85: 618-24
26. Rorke LB. Relationship of morphology of ependymoma in children to prognosis. Prg Exp Tumor Res 1987; 30: 170-4
27. Ross GW, Rubinstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989; 70: 31-6
28. Rousseau P, Habrand J-L, Sarrazin D et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Rad Oncol Biol Phys 1993; 28: 381-6
29. Sawhney N, Hall PA. Ki-67 - structure, function, and new antibodies. J Pathol 1992; 168: 161-2
30. Schiffer D, Cavalla P, Chiò A et al. Tumour cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 1994; 87: 362-70
31. Schiffer D, Chio A, Giordana MT et al. Histologic prognostic factors in ependymoma. Child's Nerv Syst 1991; 7: 177-82
32. Schröder R. Ploner C, Ernestus R-I. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index. Neurosurg Rev 1993; 16: 145-50
33. Sutton LN, Goldwein J. Perilongo G et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990-91; 16: 57-65
34. Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Rad Oncol Biol Phys 1992; 23: 313-9
35. West CR, Bruce DA, Duffner PK. Ependymomas. Factors in clinical and diagnostic staging. Cancer 1985; 56: 1812-6